Automated contouring and statistical process control for plan quality in a breast clinical trial

• Published in: Physics and imaging in radiation oncology Vol. 28; p. 100486
• Main Authors: Baroudi, Hana, Huy Minh Nguyen, Callistus I., Maroongroge, Sean, Smith, Benjamin D., Niedzielski, Joshua S., Shaitelman, Simona F., Melancon, Adam, Shete, Sanjay, Whitaker, Thomas J., Mitchell, Melissa P., Yvonne Arzu, Isidora, Duryea, Jack, Hernandez, Soleil, El Basha, Daniel, Mumme, Raymond, Netherton, Tucker, Hoffman, Karen, Court, Laurence
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.10.2023; Elsevier
• Subjects: Automated segmentation; Breast cancer; Original; Plan quality assurance; Radiotherapy clinical trial; Radiotherapy clinical trial; Breast cancer; Plan quality assurance; Automated segmentation
• ISSN: 2405-6316; 2405-6316
• DOI: 10.1016/j.phro.2023.100486

Automatic review of breast plan quality for clinical trials is time-consuming and has some unique challenges due to the lack of target contours for some planning techniques. We propose using an auto-contouring model and statistical process control to independently assess planning consistency in retrospective data from a breast radiotherapy clinical trial. A deep learning auto-contouring model was created and tested quantitatively and qualitatively on 104 post-lumpectomy patients’ computed tomography images (nnUNet; train/test: 80/20). The auto-contouring model was then applied to 127 patients enrolled in a clinical trial. Statistical process control was used to assess the consistency of the mean dose to auto-contours between plans and treatment modalities by setting control limits within three standard deviations of the data’s mean. Two physicians reviewed plans outside the limits for possible planning inconsistencies. Mean Dice similarity coefficients comparing manual and auto-contours was above 0.7 for breast clinical target volume, supraclavicular and internal mammary nodes. Two radiation oncologists scored 95% of contours as clinically acceptable. The mean dose in the clinical trial plans was more variable for lymph node auto-contours than for breast, with a narrower distribution for volumetric modulated arc therapy than for 3D conformal treatment, requiring distinct control limits. Five plans (5%) were flagged and reviewed by physicians: one required editing, two had clinically acceptable variations in planning, and two had poor auto-contouring. An automated contouring model in a statistical process control framework was appropriate for assessing planning consistency in a breast radiotherapy clinical trial.